Share Price and Basic Stock Data
Last Updated: December 9, 2025, 11:23 pm
| PEG Ratio | 0.46 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Modi Naturals Ltd operates in the edible oils and solvent extraction industry, a sector marked by volatility and changing consumer preferences. The company’s reported sales for the fiscal year ending March 2025 stood at ₹663 Cr, a substantial recovery from the ₹399 Cr recorded in FY 2024. This upward trend is particularly notable against the backdrop of declining sales in previous years, such as ₹418 Cr in FY 2023. The latest quarterly figures also reflect this growth trajectory, with sales in the quarter ending June 2025 reaching ₹155 Cr, following a steady increase from ₹120 Cr in March 2024. However, the company has experienced fluctuations, with sales dipping to ₹84 Cr in June 2023, indicating that while the recovery is promising, the business is still sensitive to external factors. This pattern suggests that Modi Naturals is gradually regaining its footing, but investors should be mindful of potential market disruptions that could affect revenue stability.
Profitability and Efficiency Metrics
Profitability metrics for Modi Naturals reflect a mixed performance, with operating profit margins (OPM) improving to 8% for FY 2025, up from just 2% in FY 2024. This increase is encouraging, particularly given the company’s struggle with profitability in earlier years, where OPM dipped to 1% in FY 2023. The net profit for FY 2025 surged to ₹31 Cr, a significant turnaround from the loss of ₹1 Cr in FY 2024, indicating a robust recovery. The interest coverage ratio stands comfortably at 4.89x, suggesting that the company can meet its interest obligations without strain. However, the cash conversion cycle has shown variability, with a concerning increase to 66 days in FY 2025, reflecting potential inefficiencies in inventory management and receivables collection. While the profitability indicators are trending positively, the efficiency metrics warrant closer scrutiny, as they directly impact the company’s cash flow and operational agility.
Balance Sheet Strength and Financial Ratios
The balance sheet of Modi Naturals shows a mixed yet improving picture. As of March 2025, total borrowings stood at ₹149 Cr, a slight reduction from ₹170 Cr in FY 2024, which is a positive sign in terms of managing debt levels. The company’s reserves have also grown to ₹108 Cr, reflecting a prudent approach to retaining earnings for future growth. The current ratio is stable at 1.22x, indicating that Modi Naturals possesses enough short-term assets to cover its short-term liabilities. However, the total debt-to-equity ratio of 1.22x suggests that the company is still relatively leveraged, which could pose risks if market conditions worsen. Additionally, the P/BV ratio at 3.75x indicates that the stock is trading at a premium to its book value, potentially reflecting investor optimism but also raising concerns about overvaluation. Overall, while the balance sheet exhibits some strengths, the leverage and valuation metrics suggest caution for investors.
Shareholding Pattern and Investor Confidence
Investor sentiment towards Modi Naturals can be gleaned from its shareholding pattern. Promoters hold a substantial 69.09% stake, indicating strong control and alignment with the company’s long-term vision. However, the absence of foreign institutional investors (FIIs) and the negligible presence of domestic institutional investors (DIIs) at 0% suggests a potential lack of confidence from larger, institutional players. The public shareholding, which stands at 30.90%, has seen some fluctuations, increasing slightly from 30.76% in December 2022 to 30.91% in March 2025. The number of shareholders has also increased to 6,634, reflecting growing interest from retail investors. This combination of strong promoter support and increasing retail interest could be a positive signal for the stock, but the lack of institutional backing raises questions about broader market confidence in the company’s growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, Modi Naturals faces both opportunities and challenges. The recovery in sales and profitability is promising, but the volatility in quarterly performance raises concerns about sustainability. Moreover, the company’s reliance on debt could become a liability if interest rates rise or if operational inefficiencies persist, particularly in the context of rising raw material costs in the edible oils sector. Investors should also be cautious of external market risks, including competition and regulatory changes impacting the food industry. On the positive side, the company’s strong promoter backing and improving financial metrics suggest a potential for growth. Investors might consider these dynamics carefully, weighing the encouraging recovery against the inherent risks of the sector and the company’s operational challenges. In a nutshell, while Modi Naturals is on a recovery path, the journey ahead requires vigilance and strategic monitoring for potential pitfalls.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Modi Naturals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modi Naturals Ltd | 479 Cr. | 360 | 667/320 | 13.1 | 107 | 0.00 % | 18.7 % | 29.2 % | 10.0 |
| IEL Ltd | 96.5 Cr. | 7.40 | 10.3/3.87 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 314 Cr. | 1.67 | 4.24/1.52 | 219 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 64.4 Cr. | 2.70 | 4.67/1.45 | 25.0 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,454 Cr. | 1,234 | 3,633/321 | 1,701 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| Industry Average | 10,350.21 Cr | 169.64 | 135.67 | 37.26 | 0.18% | 14.31% | 12.90% | 4.29 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 93 | 114 | 110 | 84 | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 |
| Expenses | 95 | 91 | 113 | 113 | 81 | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 |
| Operating Profit | 5 | 2 | 1 | -2 | 2 | 2 | -1 | 6 | 13 | 13 | 13 | 16 | 18 |
| OPM % | 5% | 2% | 1% | -2% | 3% | 2% | -1% | 5% | 9% | 9% | 7% | 8% | 11% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 1 | 0 | -3 | 1 | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 |
| Tax % | 25% | 25% | 0% | -13% | 16% | 16% | -15% | 6% | 14% | 15% | 12% | 27% | 22% |
| Net Profit | 3 | 1 | 0 | -2 | 1 | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 |
| EPS in Rs | 2.06 | 0.60 | 0.01 | -1.83 | 0.62 | 0.60 | -3.20 | 0.96 | 5.70 | 5.79 | 5.97 | 6.23 | 8.01 |
Last Updated: August 19, 2025, 12:55 pm
Below is a detailed analysis of the quarterly data for Modi Naturals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 155.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2025) to 155.00 Cr., marking a decrease of 35.00 Cr..
- For Expenses, as of Jun 2025, the value is 137.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 174.00 Cr. (Mar 2025) to 137.00 Cr., marking a decrease of 37.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 22.00%, marking a decrease of 5.00%.
- For Net Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.01. The value appears strong and on an upward trend. It has increased from 6.23 (Mar 2025) to 8.01, marking an increase of 1.78.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:51 pm
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 443 | 474 | 418 | 399 | 663 | 670 |
| Expenses | 430 | 459 | 412 | 390 | 607 | 610 |
| Operating Profit | 13 | 15 | 5 | 9 | 56 | 60 |
| OPM % | 3% | 3% | 1% | 2% | 8% | 9% |
| Other Income | 4 | 1 | 2 | 1 | 1 | 2 |
| Interest | 1 | 2 | 4 | 8 | 12 | 12 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 |
| Profit before tax | 14 | 13 | 2 | -2 | 38 | 42 |
| Tax % | 25% | 28% | 42% | -21% | 18% | |
| Net Profit | 11 | 9 | 1 | -1 | 31 | 34 |
| EPS in Rs | 8.31 | 7.40 | 0.85 | -1.05 | 23.70 | 26.00 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -88.89% | -200.00% | 3200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -70.71% | -111.11% | 3400.00% |
Modi Naturals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 49% |
| TTM: | 544% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 53% |
| 3 Years: | 33% |
| 1 Year: | 53% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 29% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:08 am
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 55 | 65 | 69 | 77 | 108 | 129 |
| Borrowings | 21 | 51 | 142 | 170 | 149 | 152 |
| Other Liabilities | 33 | 37 | 38 | 46 | 59 | 59 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 | 353 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 | 141 |
| CWIP | 0 | 0 | 91 | 0 | 16 | 54 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 102 | 139 | 144 | 157 | 169 | 158 |
| Total Assets | 121 | 165 | 263 | 306 | 330 | 353 |
Below is a detailed analysis of the balance sheet data for Modi Naturals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 108.00 Cr. (Mar 2025) to 129.00 Cr., marking an increase of 21.00 Cr..
- For Borrowings, as of Sep 2025, the value is 152.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 149.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 59.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 353.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 38.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 169.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 11.00 Cr..
- For Total Assets, as of Sep 2025, the value is 353.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2025) to 353.00 Cr., marking an increase of 23.00 Cr..
However, the Borrowings (152.00 Cr.) are higher than the Reserves (129.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Free Cash Flow | -8.00 | -36.00 | -137.00 | -161.00 | -93.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Debtor Days | 17 | 15 | 17 | 25 | 26 |
| Inventory Days | 72 | 95 | 98 | 125 | 60 |
| Days Payable | 8 | 12 | 21 | 33 | 20 |
| Cash Conversion Cycle | 81 | 98 | 94 | 117 | 66 |
| Working Capital Days | 42 | 34 | 37 | 26 | 14 |
| ROCE % | 14% | 3% | 3% | 19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Diluted EPS (Rs.) | 23.25 | -0.89 | 0.93 | 7.38 | 8.31 |
| Cash EPS (Rs.) | 29.19 | 2.13 | 2.07 | 8.52 | 9.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.35 | 68.10 | 64.59 | 61.00 | 53.62 |
| Revenue From Operations / Share (Rs.) | 498.19 | 300.47 | 330.24 | 374.75 | 349.78 |
| PBDIT / Share (Rs.) | 43.00 | 7.68 | 5.49 | 12.78 | 13.15 |
| PBIT / Share (Rs.) | 37.12 | 4.51 | 4.26 | 11.66 | 12.06 |
| PBT / Share (Rs.) | 28.33 | -1.30 | 1.47 | 10.23 | 11.04 |
| Net Profit / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| NP After MI And SOA / Share (Rs.) | 23.32 | -1.03 | 0.84 | 7.40 | 8.31 |
| PBDIT Margin (%) | 8.63 | 2.55 | 1.66 | 3.41 | 3.75 |
| PBIT Margin (%) | 7.45 | 1.50 | 1.28 | 3.11 | 3.44 |
| PBT Margin (%) | 5.68 | -0.43 | 0.44 | 2.73 | 3.15 |
| Net Profit Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| NP After MI And SOA Margin (%) | 4.68 | -0.34 | 0.25 | 1.97 | 2.37 |
| Return on Networth / Equity (%) | 25.52 | -1.52 | 1.30 | 12.13 | 15.49 |
| Return on Capital Employeed (%) | 24.71 | 3.32 | 3.09 | 17.91 | 20.85 |
| Return On Assets (%) | 9.40 | -0.45 | 0.40 | 5.66 | 8.67 |
| Long Term Debt / Equity (X) | 0.58 | 0.94 | 1.07 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.22 | 1.87 | 1.74 | 0.66 | 0.30 |
| Asset Turnover Ratio (%) | 2.08 | 1.41 | 1.95 | 3.31 | 0.00 |
| Current Ratio (X) | 1.22 | 1.24 | 1.53 | 1.59 | 2.06 |
| Quick Ratio (X) | 0.57 | 0.47 | 0.57 | 0.46 | 0.64 |
| Inventory Turnover Ratio (X) | 7.37 | 4.43 | 3.61 | 4.70 | 0.00 |
| Interest Coverage Ratio (X) | 4.89 | 1.32 | 1.97 | 8.96 | 12.85 |
| Interest Coverage Ratio (Post Tax) (X) | 3.65 | 0.82 | 1.30 | 6.19 | 9.12 |
| Enterprise Value (Cr.) | 601.08 | 422.48 | 433.31 | 295.48 | 112.19 |
| EV / Net Operating Revenue (X) | 0.90 | 1.06 | 1.04 | 0.62 | 0.25 |
| EV / EBITDA (X) | 10.51 | 41.33 | 62.37 | 18.26 | 6.74 |
| MarketCap / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| Price / BV (X) | 3.75 | 2.81 | 3.61 | 3.23 | 1.36 |
| Price / Net Operating Revenue (X) | 0.68 | 0.63 | 0.70 | 0.52 | 0.20 |
| EarningsYield | 0.06 | -0.01 | 0.00 | 0.03 | 0.11 |
After reviewing the key financial ratios for Modi Naturals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.25. This value is within the healthy range. It has increased from -0.89 (Mar 24) to 23.25, marking an increase of 24.14.
- For Cash EPS (Rs.), as of Mar 25, the value is 29.19. This value is within the healthy range. It has increased from 2.13 (Mar 24) to 29.19, marking an increase of 27.06.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.35. It has increased from 68.10 (Mar 24) to 91.35, marking an increase of 23.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 498.19. It has increased from 300.47 (Mar 24) to 498.19, marking an increase of 197.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 43.00. This value is within the healthy range. It has increased from 7.68 (Mar 24) to 43.00, marking an increase of 35.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 37.12. This value is within the healthy range. It has increased from 4.51 (Mar 24) to 37.12, marking an increase of 32.61.
- For PBT / Share (Rs.), as of Mar 25, the value is 28.33. This value is within the healthy range. It has increased from -1.30 (Mar 24) to 28.33, marking an increase of 29.63.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.32. This value is within the healthy range. It has increased from -1.03 (Mar 24) to 23.32, marking an increase of 24.35.
- For PBDIT Margin (%), as of Mar 25, the value is 8.63. This value is below the healthy minimum of 10. It has increased from 2.55 (Mar 24) to 8.63, marking an increase of 6.08.
- For PBIT Margin (%), as of Mar 25, the value is 7.45. This value is below the healthy minimum of 10. It has increased from 1.50 (Mar 24) to 7.45, marking an increase of 5.95.
- For PBT Margin (%), as of Mar 25, the value is 5.68. This value is below the healthy minimum of 10. It has increased from -0.43 (Mar 24) to 5.68, marking an increase of 6.11.
- For Net Profit Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 5. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.68. This value is below the healthy minimum of 8. It has increased from -0.34 (Mar 24) to 4.68, marking an increase of 5.02.
- For Return on Networth / Equity (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from -1.52 (Mar 24) to 25.52, marking an increase of 27.04.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 3.32 (Mar 24) to 24.71, marking an increase of 21.39.
- For Return On Assets (%), as of Mar 25, the value is 9.40. This value is within the healthy range. It has increased from -0.45 (Mar 24) to 9.40, marking an increase of 9.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.58, marking a decrease of 0.36.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.22. This value exceeds the healthy maximum of 1. It has decreased from 1.87 (Mar 24) to 1.22, marking a decrease of 0.65.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.08. It has increased from 1.41 (Mar 24) to 2.08, marking an increase of 0.67.
- For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
- For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 24) to 0.57, marking an increase of 0.10.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.37. This value is within the healthy range. It has increased from 4.43 (Mar 24) to 7.37, marking an increase of 2.94.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.89. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 4.89, marking an increase of 3.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.65. This value is within the healthy range. It has increased from 0.82 (Mar 24) to 3.65, marking an increase of 2.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 601.08. It has increased from 422.48 (Mar 24) to 601.08, marking an increase of 178.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.90, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 41.33 (Mar 24) to 10.51, marking a decrease of 30.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.75. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 24) to 3.75, marking an increase of 0.94.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 24) to 0.68, marking an increase of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.06, marking an increase of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Modi Naturals Ltd:
- Net Profit Margin: 4.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.71% (Industry Average ROCE: 14.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.52% (Industry Average ROE: 12.9%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.1 (Industry average Stock P/E: 135.67)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 405, Deepali Building, New Delhi Delhi 110019 | investors@modinaturals.com http://www.modinaturals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Modi | Chairman & Managing Director |
| Mr. Akshay Modi | Joint Managing Director |
| Mrs. Aditi Modi | Whole Time Director |
| Mr. Ankit Garg | Independent Director |
| Mrs. Ankita Singal | Independent Director |
| Mr. Udit Jain | Independent Director |
FAQ
What is the intrinsic value of Modi Naturals Ltd?
Modi Naturals Ltd's intrinsic value (as of 09 December 2025) is 333.99 which is 7.22% lower the current market price of 360.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 479 Cr. market cap, FY2025-2026 high/low of 667/320, reserves of ₹129 Cr, and liabilities of 353 Cr.
What is the Market Cap of Modi Naturals Ltd?
The Market Cap of Modi Naturals Ltd is 479 Cr..
What is the current Stock Price of Modi Naturals Ltd as on 09 December 2025?
The current stock price of Modi Naturals Ltd as on 09 December 2025 is 360.
What is the High / Low of Modi Naturals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Modi Naturals Ltd stocks is 667/320.
What is the Stock P/E of Modi Naturals Ltd?
The Stock P/E of Modi Naturals Ltd is 13.1.
What is the Book Value of Modi Naturals Ltd?
The Book Value of Modi Naturals Ltd is 107.
What is the Dividend Yield of Modi Naturals Ltd?
The Dividend Yield of Modi Naturals Ltd is 0.00 %.
What is the ROCE of Modi Naturals Ltd?
The ROCE of Modi Naturals Ltd is 18.7 %.
What is the ROE of Modi Naturals Ltd?
The ROE of Modi Naturals Ltd is 29.2 %.
What is the Face Value of Modi Naturals Ltd?
The Face Value of Modi Naturals Ltd is 10.0.